Abstract:
PROBLEM TO BE SOLVED: To provide a composition for a hydrous adhesive patch for external use which contains a specific amount of an alkyl acrylate ester compound, and to provide an adhesive patch comprising the composition.SOLUTION: The composition for a hydrous adhesive patch for external use comprises an alkyl acrylate ester compound including alkyl acrylate ester as an essential copolymer component and including the other alkyl acrylate ester and/or (meth)acrylic acid as a copolymer component. The composition for a hydrous adhesive patch for external use comprises a water-dispersible surfactant of 0.01 to 10.0 mass% to the whole of the composition for a hydrous adhesive patch for external use.
Abstract:
The present invention provides a tulobuterol adhesive patch comprising (a) a support, (b) an acrylic pressure-sensitive adhesive layer containing the percutaneously absorbing drug tulobuterol and if necessary a lipophilic oily plasticizer, and (c) a release liner, laminated in that order, wherein the acrylic pressure-sensitive adhesive is a copolymer obtained by copolymerizing an acrylic monomer which is acetoacetoxyalkyl (meth) acrylate with one or more other vinyl monomers, to yield a tulobuterol adhesive patch with excellent release and skin permeability of tulobuterol from the pressure-sensitive adhesive layer, low skin irritation and excellent safety.
Abstract:
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for external application and an adhesive skin patch capable of improving releasability, transdermal absorbability and stability of loxoprofen and a salt thereof and capable of reducing aggravation of irritation to skin.SOLUTION: An adhesive skin patch includes a support and an adhesive layer laminated on the support. The adhesive layer includes a styrene-isoprene-styrene copolymer, a tackifier, a plasticizer, sodium loxoprofen, oxyacid and N-methyl-2-pyrrolidone. Preferably, the adhesive layer includes no crotamiton.